Retraction. Extracellular matrix fibronectin increases prostaglandin E2 receptor subtype EP4 in lung carcinoma cells through multiple signaling pathways: the role of AP-2.
Publication/Presentation Date
7-15-2011
Volume
286
Issue
28
First Page
25416
Last Page
25416
ISSN
1083-351X
Published In/Presented At
Han, S., Ritzenthaler, J. D., Wingerd, B., Rivera, H. N., & Roman, J. (2011). Retraction. Extracellular matrix fibronectin increases prostaglandin E2 receptor subtype EP4 in lung carcinoma cells through multiple signaling pathways: the role of AP-2. The Journal of biological chemistry, 286(28), 25416. https://doi.org/10.1074/jbc.a111.610308
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
21879499
Department(s)
Administration and Leadership
Document Type
Article
COinS